The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
Clinical trial NCT03804372 · TERMINATED
Trial details
- NCT number
- NCT03804372
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2024-05-22
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.